Company Filing History:
Years Active: 2017-2026
Title: Innovations in Cancer Detection by Michael Bousamra
Introduction
Michael Bousamra is an accomplished inventor based in Louisville, KY (US). He has made significant contributions to the field of cancer detection through innovative methods that utilize exhaled breath as a diagnostic tool. With a total of 3 patents, Bousamra's work is paving the way for non-invasive cancer screening techniques.
Latest Patents
Bousamra's latest patents include two groundbreaking methods for cancer detection. The first patent focuses on the non-invasive detection of cancer originating in tissue outside of the lung using exhaled breath. This method involves detecting elevated levels of carbonyl-containing volatile organic compounds (VOCs) that serve as biomarkers for cancer. The process includes obtaining exhaled breath, forming adducts of the VOCs with a reactive chemical compound, and quantifying these adducts to establish subject values. These values are then compared to threshold healthy specimen values to screen for cancer.
The second patent addresses the non-invasive detection of lung cancer specifically. Similar to the first, this method also detects elevated levels of carbonyl-containing VOCs in exhaled breath. The steps involved are akin to those in the first patent, emphasizing the importance of quantifying adducts and comparing them to healthy specimen values for effective lung cancer screening.
Career Highlights
Michael Bousamra is affiliated with the University of Louisville Research Foundation, Inc., where he continues to advance his research in cancer detection. His innovative approaches have garnered attention in the medical community, highlighting the potential for non-invasive diagnostic methods.
Collaborations
Bousamra collaborates with notable colleagues, including Xiaoan Fu and Michael H. Nantz. Their combined expertise contributes to the development of effective cancer detection technologies.
Conclusion
Michael Bousamra's work in cancer detection through exhaled breath represents a significant advancement in non-invasive diagnostic methods. His innovative patents are set to transform the landscape of cancer screening, offering hope for earlier detection and improved patient outcomes.